Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 6 of 6
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.89Thymoma 14742432 Subcellular localization and targeting of N-acetylglucosaminyl phosphatidylinositol de-N-acetylase, the second enzyme in the glycosylphosphatidylinositol biosynthetic pathway. ongoing research
unassigned
3
0
Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.89Trypanosomiasis, African 12364327 Cloning of Trypanosoma brucei and Leishmania major genes encoding the GlcNAc-phosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol biosynthesis that is essential to the African sleeping sickness parasite. causal interaction
therapeutic application
unassigned
3
1
0
Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.89Trypanosomiasis, African 15817455 The N-acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase of glycosylphosphatidylinositol biosynthesis is a zinc metalloenzyme. therapeutic application
unassigned
4
0
Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.89Trypanosomiasis, African 22222041 Inhibitors incorporating zinc-binding groups target the GlcNAc-PI de-N-acetylase in Trypanosoma brucei, the causative agent of African sleeping sickness. causal interaction
therapeutic application
unassigned
2
4
0
Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.89Trypanosomiasis, African 24589444 Fragment screening reveals salicylic hydroxamic acid as an inhibitor of Trypanosoma brucei GPI GlcNAc-PI de-N-acetylase. therapeutic application
unassigned
1
0
Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.89Trypanosomiasis, African 26476127 In silico drug re-purposing against African sleeping sickness using GlcNAc-PI de-N-acetylase as an experimental target. ongoing research
therapeutic application
unassigned
1
4
0
Results 1 - 6 of 6